Vetoquinol: Announcement of the Availability of the Half-Year Financial Report to June 30, 2023
October 09 2023 - 8:38AM
Business Wire
Regulatory News:
Vetoquinol (Paris:VETO) announced today that it has made
available to the public and filed with the Autorité des marchés
financiers its Half-Year Financial Report to June 30, 2023.
The Half-Year Financial Report can be consulted on Vetoquinol's
website at www.vetoquinol.com/en/publications in the Regulated
Information section.
Next update: Q3 2023 Sales, October 26, 2023 after market
close
ABOUT VETOQUINOL Vetoquinol is a leading global animal health
company that supplies drugs and non-medicinal products for the farm
animals (cattle and pigs) and pet (dogs and cats) markets. As an
independent pure player, Vetoquinol designs, develops and sells
veterinary drugs and non-medicinal products in Europe, the Americas
and the Asia Pacific region. Since its foundation in 1933,
Vetoquinol has pursued a strategy combining innovation with
geographical diversification. The Group’s hybrid growth is driven
by the reinforcement of its product portfolio coupled with
acquisitions in high potential growth markets. Vetoquinol employed
2,497 people as of June 30, 2023.
Vetoquinol has been listed on Euronext Paris since 2006 (symbol:
VETO). The Vetoquinol share is eligible for the French PEA and
PEA-PME personal equity plans.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231009312948/en/
FOR MORE INFORMATION, CONTACT:
VETOQUINOL Investor Relations Fanny Toillon Tel.: +33
(0)3 84 62 59 88 relations.investisseurs@vetoquinol.com
KEIMA COMMUNICATION Investor & Media Relations
Emmanuel Dovergne Tel.: +33 (0)1 56 43 44 63
emmanuel.dovergne@keima.fr
Vetoquinol (EU:VETO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vetoquinol (EU:VETO)
Historical Stock Chart
From Sep 2023 to Sep 2024